Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Partnering for Impact - General Pool

University of Calgary

$149,442.00

Partnering for Impact: Establishing a Patient, Caregiver, and Clinician-identified Research Agenda for Sickle Cell Disease in Canada

FY 2025-26

Summary
Sickle Cell Disease (SCD) is the most common inherited blood disorder in which abnormal hemoglobin causes red blood cells (RBCs) to become "sickled." Sickled cells can obstruct small vessels, leading to organ damage and characterized by intense pain. Despite the growing, global burden associated with SCD, scientific research in Canada remains underfunded and underprioritized. Furthermore, the communities most affected with SCD have long faced racism and lack of disease awareness which has contributed directly or indirectly to inadequate healthcare and worsen outcomes. Patient-oriented research is critical to advancing quality and building trust to achieve equity of the healthcare systems for those with SCD. In partnership with Sickle Cell Disease Association of Canada we will establish a patient, caregiver, and clinician-identified research agenda for sickle cell disease in Canada. This work will be guided by the priority setting partnership methodology established by the James Lind Alliance (JLA; http://www.jla.nihr.ac.uk), considered the gold standard for establishing patient-oriented research agendas. The SCD PSP will be focused on English- and French-speaking Canadians with a diagnosis of SCD, family members and caregivers of SCD and clinicians who provide direct care to SCD patients. Overall, the expertise of the research team spans multiple disciplines, geographic locations, and areas of content and methodological expertise, which provides the necessary synergy to guide the establishment of a patient-oriented research agenda in SCD. The proposed research comes at a critical time within the Canadian research and political landscape for SCD. Currently sitting under review with the Canadian Senate is Bill S-201, a groundbreaking legislative effort to transform care and support for SCD in Canada. In line with Bill S-201, the proposed PSP will generate an immediate, evidence-informed, and actionable research agenda to guide future SCD research in Canada.
Program
Catalyst Grant: Partnering for Impact - General Pool
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
556734
Name
Schulte Fiona S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Catalyst Grant: Partnering for Impact
Projecttitle
Partnering for Impact: Establishing a Patient, Caregiver, and Clinician-identified Research Agenda for Sickle Cell Disease in Canada
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$149,442
Cihrequipment2
$0
Programname2
Catalyst Grant: Partnering for Impact - General Pool
Keyworddelim
Hematology; Patient-Oriented Research; Sickle Cell Anemia
Abstract
Sickle Cell Disease (SCD) is the most common inherited blood disorder in which abnormal hemoglobin causes red blood cells (RBCs) to become "sickled." Sickled cells can obstruct small vessels, leading to organ damage and characterized by intense pain. Despite the growing, global burden associated with SCD, scientific research in Canada remains underfunded and underprioritized. Furthermore, the communities most affected with SCD have long faced racism and lack of disease awareness which has contributed directly or indirectly to inadequate healthcare and worsen outcomes. Patient-oriented research is critical to advancing quality and building trust to achieve equity of the healthcare systems for those with SCD. In partnership with Sickle Cell Disease Association of Canada we will establish a patient, caregiver, and clinician-identified research agenda for sickle cell disease in Canada. This work will be guided by the priority setting partnership methodology established by the James Lind Alliance (JLA; http://www.jla.nihr.ac.uk), considered the gold standard for establishing patient-oriented research agendas. The SCD PSP will be focused on English- and French-speaking Canadians with a diagnosis of SCD, family members and caregivers of SCD and clinicians who provide direct care to SCD patients. Overall, the expertise of the research team spans multiple disciplines, geographic locations, and areas of content and methodological expertise, which provides the necessary synergy to guide the establishment of a patient-oriented research agenda in SCD. The proposed research comes at a critical time within the Canadian research and political landscape for SCD. Currently sitting under review with the Canadian Senate is Bill S-201, a groundbreaking legislative effort to transform care and support for SCD in Canada. In line with Bill S-201, the proposed PSP will generate an immediate, evidence-informed, and actionable research agenda to guide future SCD research in Canada.
Competitiondate
202510
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schulte, Fiona S; Dordunoo, Dzifa; Tutelman, Perri
Approvedterm
1 an 0 mois
Cihrcontribution2
VP's Office, LHS~ $149,442~ $0~